Loss of SMARCB1 evokes targetable epigenetic vulnerabilities in epithelioid sarcoma.
Jin JX, Fuchslocher F, Carreno-Gonzalez M, Zahnow F, Ceranski AK, Will R, Helm D, Bestvater F, Banito A, Imle R, Ohmura S, Cidre-Aranaz F, Grünewald TGP.
Jin JX, et al.
Cancer Commun (Lond). 2025 Jan 20. doi: 10.1002/cac2.12665. Online ahead of print.
Cancer Commun (Lond). 2025.
PMID: 39834137
No abstract available.